Skip to Main Content
Contribute Try STAT+ Today

The pharmaceutical industry’s response to the novel coronavirus may not rescue its ailing reputation. But it will, apparently, be televised — and the footage could nudge the public’s perception of how the drug business works.

That, at least, is the thinking behind a 30-minute weekly show from the multinational drug company Johnson & Johnson being launched Tuesday. The eight-episode series, which will be broadcast live online, will focus on the company’s efforts to find a vaccine for the virus that causes Covid-19. J&J hired journalist Lisa Ling, of CNN’s “This Is Life,” to host the program.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.